“Blood is quite a peculiar kind of juice“—that is what Mephisto knew, according to Goethe’s “Faust“. But if blood really is very special, then erythropoietin (EPO) must be a very special molecule, as it triggers the production of our red blood cells.
After ten years of intense research, American scientists have now succeeded in making a fully synthetic version of this special molecule. This achievement represents a landmark advance in the chemical synthesis of complex biological molecules from basic building blocks.
EPO is not actually one compound but a large family of molecules. Known as glycoproteins, the structures are composed of a protein decorated with four carbohydrate sectors. The protein portion is always the same, as are the locations at which the carbohydrate domains are attached. Yet, in endogenous EPO protein, there are a wide variety of different carbohydrate sectors that may be appended to the protein. It has not been possible to access naturally occurring EPO as a homogeneous, pure molecule. By adopting the tools of chemical synthesis, the investigators were able to make, for the first time, pure “wild type” EPO glycoprotein incorporating the natural amino acid sequence and four carbohydrate sectors of strictly defined structure.
Extension of this strategy will enable scientists to make numerous versions of the molecule and to study how differences in the chemical structure of the carbohydrate domains may affect how the glycoprotein induces the production of red blood cells.
The structure of the synthetic EPO was verified by mass spectrometry. Tests using stem cells proved the effectiveness of the synthesized EPO: like its natural counterpart, the synthetic EPO triggered the formation of red blood cells from stem cells.About the Author
Samuel J. Danishefsky | Angewandte Chemie
How Cells Take Out the Trash
23.04.2014 | NIH, National Institute of General Medical Sciences (NIGMS)
Ravens understand the relations among others
23.04.2014 | University of Vienna
01.04.2014 | Event News
28.03.2014 | Event News
24.03.2014 | Event News
23.04.2014 | Architecture and Construction
23.04.2014 | Life Sciences
23.04.2014 | Health and Medicine